Cancer Interception

The goal of the Cancer Interception Research Program is to identify cellular and molecular events (induced by environmental exposures) associated with cancer initiation and progression that can be translated into novel tools for early detection and prevention of cancers that disproportionally impact the BMC population.

Program Co-directors:
David Sherr, PhD [School of Public Health]
Tony Godfrey, PhD [School of Medicine]

Program Themes:

• Early Detection (Director: TBD)
  • Screening
  • Diagnostic
  • Recurrence
• Prevention (Director: D. Sherr)
  • Carcinogenic exposures (molecular targets)
  • Companion Diagnostics / Chemopreventative approaches